From: Current ciprofloxacin usage in children hospitalized in a referral hospital in Paris
Patients without CF (n = 77) | Patients with CF (n = 21) | |
---|---|---|
Bacteriological finding n (%) | 40 (51.9) | 21 (100) |
Presence of P. aeruginosa n (%) | 13 (16.9) | 20 (95.2) |
Mixed bacterial infection n (%) | 3 (3.9) | 1 (4.8) |
Antibiotic combination n (%) | 65 (84.4) | 21 (100) |
Indication for ciprofloxacin | ||
Active infection n (%) | 76 (98.7) | 21 (100) |
Bronchopulmonary n (%) | 25 (32.4) | 21 (100) |
Urinary tract n (%) | 8 (10.4) | 0 |
Intra-abdominal infection n (%) | 7 (9.1) | 0 |
Bloodstream infection/catheter infection n (%) | 2 (2.6)/4 (5.2) | 0 |
Operative site infection n (%) | 5 (6.5) | 0 |
Bone or joint n (%) | 4 (5.2) | 0 |
Cerebral n (%) | 4 (5.2) | 0 |
Mediastinitis$ n (%) | 3 (3.9) | 0 |
Endocarditis n (%) | 2 (2.6) | 0 |
Miscellaneous§ n (%) | 12 (15.6) | 0 |
Prophylaxis n (%) | 1 (1.3) | 0 |